ERBB2 and breast cancer: Although cyclin D1 knockout mice were shown to be resistant to the formation of Erbb2 or Ras oncogene-induced breast cancers, cyclin D1 deficiency has not been shown to be protective against tumor formation induced by c-Myc or Wnt-1 [54].